434 related articles for article (PubMed ID: 27683034)
1. Intraglomerular crosstalk elaborately regulates podocyte injury and repair in diabetic patients: insights from a 3D multiscale modeling study.
Tan H; Yi H; Zhao W; Ma JX; Zhang Y; Zhou X
Oncotarget; 2016 Nov; 7(45):73130-73146. PubMed ID: 27683034
[TBL] [Abstract][Full Text] [Related]
2. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
[TBL] [Abstract][Full Text] [Related]
3. The glomerular podocyte as a target of growth hormone action: implications for the pathogenesis of diabetic nephropathy.
Kumar PA; Brosius FC; Menon RK
Curr Diabetes Rev; 2011 Jan; 7(1):50-5. PubMed ID: 21067510
[TBL] [Abstract][Full Text] [Related]
4. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli.
Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L
Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy.
Yamaguchi Y; Iwano M; Suzuki D; Nakatani K; Kimura K; Harada K; Kubo A; Akai Y; Toyoda M; Kanauchi M; Neilson EG; Saito Y
Am J Kidney Dis; 2009 Oct; 54(4):653-64. PubMed ID: 19615802
[TBL] [Abstract][Full Text] [Related]
6. PRMT1 mediates podocyte injury and glomerular fibrosis through phosphorylation of ERK pathway.
Zhu Y
Biochem Biophys Res Commun; 2018 Jan; 495(1):828-838. PubMed ID: 29129692
[TBL] [Abstract][Full Text] [Related]
7. The phenotypes of podocytes and parietal epithelial cells may overlap in diabetic nephropathy.
Andeen NK; Nguyen TQ; Steegh F; Hudkins KL; Najafian B; Alpers CE
Kidney Int; 2015 Nov; 88(5):1099-107. PubMed ID: 26376129
[TBL] [Abstract][Full Text] [Related]
8. Intra-renal and urinary mRNA expression of podocyte-associated molecules for the estimation of glomerular podocyte loss.
Wang G; Lai FM; Lai KB; Chow KM; Kwan BC; Li KT; Szeto CC
Ren Fail; 2010 Jan; 32(3):372-9. PubMed ID: 20370455
[TBL] [Abstract][Full Text] [Related]
9. IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes.
Lay AC; Hale LJ; Stowell-Connolly H; Pope RJP; Nair V; Ju W; Marquez E; Rollason R; Hurcombe JA; Hayes B; Roberts T; Gillam L; Allington J; Nelson RG; Kretzler M; Holly JMP; Perks CM; McArdle CA; Welsh GI; Coward RJM
Diabetologia; 2021 Jul; 64(7):1690-1702. PubMed ID: 33758952
[TBL] [Abstract][Full Text] [Related]
10. Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy.
Zheng S; Carlson EC; Yang L; Kralik PM; Huang Y; Epstein PN
J Am Soc Nephrol; 2008 Nov; 19(11):2077-85. PubMed ID: 18632844
[TBL] [Abstract][Full Text] [Related]
11. Podocyte hypertrophy in diabetic nephropathy.
Kim NH
Nephrology (Carlton); 2005 Oct; 10 Suppl():S14-6. PubMed ID: 16174280
[TBL] [Abstract][Full Text] [Related]
12. Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes.
Stieger N; Worthmann K; Teng B; Engeli S; Das AM; Haller H; Schiffer M
Metabolism; 2012 Aug; 61(8):1073-86. PubMed ID: 22365040
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of α3β1-Integrin in Podocytes in Early-Stage Diabetic Nephropathy.
Sawada K; Toyoda M; Kaneyama N; Shiraiwa S; Moriya H; Miyatake H; Tanaka E; Yamamoto N; Miyauchi M; Kimura M; Wada T; Fukagawa M
J Diabetes Res; 2016; 2016():9265074. PubMed ID: 27340677
[TBL] [Abstract][Full Text] [Related]
14. The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy?
Reddy GR; Kotlyarevska K; Ransom RF; Menon RK
Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):32-6. PubMed ID: 18090667
[TBL] [Abstract][Full Text] [Related]
15. Automated image analysis of a glomerular injury marker desmin in spontaneously diabetic Torii rats treated with losartan.
Kakimoto T; Okada K; Hirohashi Y; Relator R; Kawai M; Iguchi T; Fujitaka K; Nishio M; Kato T; Fukunari A; Utsumi H
J Endocrinol; 2014 Jul; 222(1):43-51. PubMed ID: 24781258
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D3 ameliorates podocyte injury through the nephrin signalling pathway.
Trohatou O; Tsilibary EF; Charonis A; Iatrou C; Drossopoulou G
J Cell Mol Med; 2017 Oct; 21(10):2599-2609. PubMed ID: 28664547
[TBL] [Abstract][Full Text] [Related]
17. Exosomes from high glucose-treated glomerular endothelial cells trigger the epithelial-mesenchymal transition and dysfunction of podocytes.
Wu X; Gao Y; Xu L; Dang W; Yan H; Zou D; Zhu Z; Luo L; Tian N; Wang X; Tong Y; Han Z
Sci Rep; 2017 Aug; 7(1):9371. PubMed ID: 28839221
[TBL] [Abstract][Full Text] [Related]
18. Dissection of Glomerular Transcriptional Profile in Patients With Diabetic Nephropathy: SRGAP2a Protects Podocyte Structure and Function.
Pan Y; Jiang S; Hou Q; Qiu D; Shi J; Wang L; Chen Z; Zhang M; Duan A; Qin W; Zen K; Liu Z
Diabetes; 2018 Apr; 67(4):717-730. PubMed ID: 29242313
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of podocyte lesion in patients with diabetic nephropathy: Wilms' tumor-1 protein used as a podocyte marker.
Su J; Li SJ; Chen ZH; Zeng CH; Zhou H; Li LS; Liu ZH
Diabetes Res Clin Pract; 2010 Feb; 87(2):167-75. PubMed ID: 19969384
[TBL] [Abstract][Full Text] [Related]
20. Islet transplantation restores the damage of glomerulus filtration membrane in a rat model of streptozotocin-induced diabetic nephropathy.
Ziqiang X; Yunqiang H; Hongxing F; Jinjun W; Yong C
J Pak Med Assoc; 2016 Mar; 66(3):296-301. PubMed ID: 26968280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]